In person
As in the previous years ZoBio will attend the European Conference on Magnetic Resonance, which will take place in Göteborg, Sweden
Stephan Theisgen will present a poster demonstrating how strategically integrating solution-state NMR into commercial drug discovery programs provides critical structural insights across the early preclinical pipeline.
The poster highlights how NMR complements biochemical assays, biophysical screening, AI-driven modeling, X-ray crystallography, and cryo-EM by delivering dynamic, site-specific information on ligand–target interactions. Practical examples showcase the application of NMR for fragment screening, cryptic pocket identification, hit validation, rapid verification of computational and structural models, and overcoming crystallization challenges.
By implementing scalable and cost-effective NMR workflows with rapid turnaround times, ZoBio enables clients to make informed decisions and confidently advance their small-molecule discovery programs.
Interested in learning how solution-state NMR can support your drug discovery? Contact us!